The UAB NF Program is internationally recognized for its contributions to outstanding clinical care, research, and education related to all forms of neurofibromatosis (NF1, NF2, and schwannomatosis). We are the national coordinating center for the NF Clinical Trials Consortium, funded by the Department of Defense to perform clinical trials for all forms of neurofibromatsis.
UAB researchers work to unravel the complex genetic disease neurofibromatosis type 1It is easy to tell a medical research story that has a simple and dramatic moment. But disease is often much more complex, and the work to understand it can be painstaking.
A vivid example of that is seen in the UAB Medical Genomics Laboratory, headed by Ludwine Messiaen, Ph.D., professor of genetics. This lab offers clinical genetic testing for a broad array of common and rare genetic disorders. One of the most confounding is neurofibromatosis type 1.
Clinical Services: Our goal is to deliver outstanding care for patients and families through integrated clinical and laboratory services. For some conditions, we are considered a national and international referral source.
Research: We seek to expand knowledge and create new applications through laboratory and clinical research along the continuum from fundamental studies to preclinical investigations, to bench-to bedside translation, to clinical practice and community implementation.